Clinical Trial Update: Grass Pollen Allergen Immunotherapy Tablet (AIT) Time Course Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a grass pollen allergen immunotherapy tablet in allergic rhinitis; study completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis

Snippet

Sponsor: Imperial College London | Conditions: Allergic Rhinitis | Phase 2 | Status: COMPLETED | Results posted: 2019-12-04